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Objectives: The aim of this experimental study was to compare the effectiveness and reliability of
lovastatin and hyaluronic acid þ carboxymethyl cellulose (Sepraﬁlm).
Materials and methods: Thirty two female WistareAlbino rats weighing between 250 and 300 g were
used in the study. The rats were divided into four groups as sham, control, lovastatin and Sepraﬁlm each
of which contained 8 rats. All rats were sacriﬁced on the 14th day after surgery. Macroscopic adhesion,
microscopic adhesion and tPA, MDA and NO values were evaluated.
Results: Macroscopic adhesion formation was signiﬁcantly lower in the sham and study groups than in
the control group (p < 0.05). Microscopic classiﬁcation adhesion formation was signiﬁcantly lower in the
sham and study groups than in the control group (p < 0.05), and the tPA, MDA and NO values showed
statistically signiﬁcant differences among the groups.
Conclusion: Lovastatin and Sepraﬁlm were equally effective in preventing postoperative intra abdominal
adhesions. The study groups were showed signiﬁcant superiority to the control group.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Postoperative intra abdominal adhesions are the most frequent
complication of surgery, although often not recognized as such.
After abdominal surgery, 67e93% of patients develop adhesions.1,2
Between 0.3 and 10.7% of patients develop intestinal obstruction
after intra-abdominal surgery.3 Other consequences of intra
abdominal adhesions may cause infertility (15e20%), chronic pelvic
pain, dyspareunia and ectopic pregnancy. In addition difﬁcult reo-
perative surgery, increase in bleeding, injury to adjacent organs and
such effects may occur.3,4 The economic burden of adhesion-related
hospital readmissions and reoperations is enormous.5,6 The path-
ophysiology of adhesion formation has been researched widely.
This process is activated by tissue factor or more speciﬁcally by the
ﬁbrin gel matrix.7 Fibrinogen, is a soluble protein and is located
between the tissues and blood products.
It reacts with thrombin and forms ﬁbrin monomers and ﬁbrin-
ogen is polymerized. Initially the ﬁbrin polymers are soluble and: þ90 354 2122789.
.
ciates Ltd. Published by Elsevier Ltreveal injured surfaces during surgery. If they stay in contact with
coagulation factors such as Factor XIIIa for a long time, the ﬁbrin
polymers forma ﬁbrin-gel matrix.8
Under normal circumstances, this ﬁbrogenesis is in balancewith
ﬁbrinolysis. The process of ﬁbrinolysis is driven by the enzyme
plasmin, which is derived from its inactive substrate plasminogen
by tissue-type plasminogen activator (tPA). In turn, tPA is inhibited
in its reaction by plasminogen activator inhibitor-1 (PAI-1), to
maintain a balance. In the abdominal cavity, tPA is responsible for
95% of plasminogen conversion.7 Intra-abdominal surgery disturbs
the balance between tPA and PAI-1resulting in decreased ﬁbrino-
lytic activity and an increase in ﬁbrin exudate, eventually leading to
an increase in adhesion formation.9
Sodium hyaluronate/carboxymethyl cellulose(HA/CMC)(Se-
praﬁlm) is a bioreabsorbable membrane which reduces the for-
mation of adhesions. This membrane is transformed into a gel
within 24 h after application. During the recovery phase of
peritoneal adhesion it prevents the formation of damaged tissues
by providing physical separation. All traces of the gel are excreted
from the body within 28 days.10,11 Clinical and experimental
studies have shown that Sepraﬁlm prevented intra-abdominal
adhesions.12e14d. All rights reserved.
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expression of tissue factor and platelet activation and can cause a
major reduction in the risk of stroke and cerebral ischemia.
Because of this ﬁbrinolytic activity of statins, suggested their
possible use in the treatment of intra-abdominal postoperative
adhesions. In an experimental adhesion formation model Aorans
and et al. found that intraperitoneal application of lovastatin and
atorvastatin in rats reduced postoperative adhesion.15
In our study, we aimed to evaluate the effects of lovastatin and
to compare it with hyaluronic acid þ carboxy methyl cellulose
which has previously been proved to be effective in many clinical
and experimental studies.2. Materials and methods
2.1. Animals and preoperative preparation
This experimental study was performed at Erciyes University’s
Hakan Cetinsaya Experimental and Clinical Research Center in
2008. The study was approved by the Ethics Committee
(Date:21.11.2007, number:07/11). Thirty two female WistareAlbino
rats weighing between 250 and 300 g were used in the study. All
rats were fed ad libitum with standard rat chow and tap water. All
subjects were kept in 12 h darkness and 12 h light for before and
after study (at a standard temperature of 22 C). The subjects
were kept under observation at least 48 h before they were
included in the study. After 12 h of starvation, the subjects were
weighed and divided randomly into four groups as sham, control
and two study groups each containing 8 rats.
Group 1 (sham):After laparotomy the caecum, ileum and right
corner of the uterus was palpated and the abdomen was closed.
Group 2 (control): The experimental model was performed in
this group of rats and before closing the abdomen 5 cc saline was
administered intraperitoneally.
Group 3 (lovastatin): The experimental model was performed in
this group of rats and before closing the abdomen 30 mg/kg lova-
statinwas administered intraperitoneally (SigmaM2147, mevinolin
from Aspergillus sp).
Group 4 (Sepraﬁlm): The experimental model was performed in
this group of rats and before closing the abdomen 30  20 mm
Sepraﬁlm was applied intraperitoneally. (HA þ CMC- Sepraﬁlm-
Genzyme Corporation, Cambridge, MA, USA).2.2. Operative technique
Fifty mg/kg ketamine -HCL(Ketalar, Pﬁzer, Turkey) was admin-
istered intraperitoneally as an anesthetic agent. After administering
the anesthetic agent the rats’ abdomens were shaved with a shaver
and stained with povidone-iodine. A 3-cm midline laparotomy
incision was performed under sterile conditions. In this study the
caecum, ileum and right corner of the uterus were abreded and
bleeding points were created with the help of a lancet and only
serosal injury was created by the surgeon blinded to group allo-
cation. After this operation saline solution was administered to the
peritoneal cavity of rats in the control group, while Sepraﬁlm and
lovastatin were administered intraperitoneally in the study groups.
The peritoneal fascia was closed with 4/0 PDS and the skin with 3/
0 silk at the end of the operation. All rats were returned to their
cages after the operation and kept at an ambient temperature of
22 C. They were fed with standard rat diet after surgery. In the
control group one rat died during the study on the ﬁrst post-
operative day and a new rat was added. All rats were sacriﬁced with
a high dose of anesthetic on 14th day after surgery. After being
sacriﬁced, a paramedian laparotomy was performed immediately;the ceacum and abdominal side wall were evaluated for adhesion
and 2 g tissue was taken from the adhesion region.
2.3. Macroscopic evaluation
Macroscopic evaluation of the intraperitoneal cavity was per-
formed by a surgeon blinded to group allocation. Therefore, the
data analysis was performed in a blinded fashion.
Majuzi classiﬁcation is used for the evaluation of postoperative
intraperitoneal adhesions.16 According to the classiﬁcation the
following grades are used: Grade 0: no adhesion, Grade 1: very
little and irregular adhesion, Grade 2: easily separable medium
intensity adhesion, Grade 3: intense, not easily separable regular
adhesion, Grade 4: very hard, not easily separable and homoge-
neous adhesion.
2.4. Histopathologic evaluation
After macroscopic evaluation, samples were taken from the
ﬁbrous bands between the caecum and the peritoneum and a
histopathological examination was performed by a pathologist
blinded to the groups. Tissue samples were ﬁxed for 12 h in a 10%
buffered neutral formalin solution. After a routine follow-up, the
samples were embedded in parafﬁn blocks and sections of 4e5 mm
thickness were stained with hematoxylin and eosin (H&E) and.
These were ﬁnally examined under a light microscope. The
Zühlke scoring system was used to assess the adhesions.17 Ac-
cording to the scoring system the following grades were used 1:
Loose connective tissue, cell-rich old and new ﬁbrin, ﬁne reticulin
ﬁbers 2: Connective tissue with cell and capillaries, few collogen
ﬁbers, 3: Connective tissue ﬁrmer, fewer cells, more vessels, few
elastic and smooth muscle ﬁbers 4: old ﬁrm granulation tissue, cell
poor, serosal layers hardly distinguishable.
2.5. Measurement of nitric oxide, malondialdehyde
Nitric oxide (NO), malondialdehyde (MDA) and tissue plasmin-
ogen activator (tPA) parameters were examined in the biochemical
evaluation.
For measurement of malondialdehyde (MDA),18 0.5 ml of serum
was added to 2.5 ml of 20% TCA and then 1 ml of 0.67% thio-
barbituric acid (TBA). The mixture was incubated at 100 C for
30min. After cooling, the samplewas extractedwith 4ml n-butanol
and centrifuged at 3000 rpm for 10 min. The absorbances of the
extract weremeasured at 535 nm and the results were expressed as
mmol/l, using the extinction coefﬁcient of 1.56  105 l/mmol cm.
Nitrate/nitrite in serumwas determined according to the Griess
reaction.19 A 100 ml measure of serum was incubated for 30 min at
37 C in the presence of 0.2 U/ml nitrate reductase, 50 mmol/l
Hepes buffer, 5 mmol/l FAD and 0.1 mmol/l NADPH in a total volume
of 500 ml. Following incubation, 5 ml of lactic dehydrogenase (1500
U/ml) and 50 ml of 100 mmol/l pyruvic acid were added to oxidize
any unreacted NADPH. The sample was then incubated for 10 min
at 37 C. One milliliter of premixed Griess reagent (equivolume of
0.2% naphthylethylenediamine and 2% sulfanilamide in 5% phos-
phoric acid) was then added. After 10-min incubation at room
temperature, the absorbances of the samples were determined at
543 nm. Nitrate concentrations were calculated from the difference
between the values obtained in the presence and absence of nitrate
reductase. The results were expressed as mmol/l, using known
concentrations of nitrate.
For measurement of tissue plasminogen activator (tPA) a rat tPA
ELISA Kit (Innovative Research 21315 Hilltop, Southﬁeld) was used.
tPA binds to the capture antibody coated on the microtiter plate.
Free, latent and complexed tPAwill bind to the capture antibody. An
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opment at 450 nm. A standard calibration curve is prepared along
with the samples to be measured using dilutions of puriﬁed tPA.
2.6. Statistical analysis
Statistical analysis was performed by using SPSS version 12.0
(SPSS Inc., Chicago, IL, USA) for Windows Vista. Data are expressed
as mean  standard error (X  SE) and median (minemax). Krus-
kaleWallis and ManneWhitney U tests were used for macroscopic
and histopathological values, and the post-hoc Scheffe (ANOVA)
test was used for a comparison of biochemical values. P
values < 0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. Macroscopic evaluation
Four rats (50%) hadno adhesions in the shamgroup. Seven rats in
the control group (87%) had adhesions in different stages. Of these
25% were grade 3 adhesions. The total adhesion scores of the sham
group, lovastatin group and Sepraﬁlm group were signiﬁcantly
lower than the control groups (p ¼ 0.019). There was no signiﬁcant
difference among the sham, Sepraﬁlm and lovastatin groups.
(p ¼ 0558, p ¼ 0819, p ¼ 0680) (respectively) (Table 1 and Fig. 1).
3.2. Histopathological evaluation
Histopathological evaluation was performed according to the
microscopic adhesion classiﬁcation, where the thickness of con-
nective tissue, reticulin and collagen ﬁbers, cells and capillary
vessels were taken into consideration. The total adhesion scores of
the sham group, lovastatin group and Sepraﬁlm group were
signiﬁcantly lower than the control groups (p ¼ 0.08) (p < 0.05).
There was no signiﬁcant difference among the sham, Sepraﬁlm and
lovastatin groups. (p ¼ 0.28, p ¼ 0.02, p ¼ 0. 28) (respectively)
(Table 1 and Fig. 2).
3.3. Biochemical evaluation
There was statistically signiﬁcant difference in tPA, MDA and NO
levels (p ¼ 0.015, p ¼ 0.003, p ¼ 0.026)(respectively). MDA and NO
levels were higher in the control group. There was a statistically
signiﬁcant difference among the control groups and the other
groups. In our study, tPA values were higher in the lovastatin group.
There was a statistically signiﬁcant difference between the lova-
statin group and the control group (p ¼ 0.048) (p < 0.05). However,
no signiﬁcant difference was found when the lovastatin group was
compared with the sham and Sepraﬁlm groups (Table 2).
4. Discussion
Postoperative intra abdominal adhesions, cause serious
morbidity like pelvic pain, infertility, bowel obstruction and ure-
teral obstruction.4,20 These problems can cause serious morbidity
and mortality and may require reoperation for some patients. In
addition, previous studies have shown that intra abdominalTable 1
Macroscopic and microscopic adhesion score values of the groups.
Control Sham
Macroscopic ﬁbrosis score (M  SD) 2.0  1.06 0.75 
Microscopic adhesion score (M  SD 1.75  0.70 0.75 
M:Mean, SD:Standart Deviation.adhesions prolong planned or emergency re-laparotomy time and
exploration and increase iatrogenic bowel injury.5,6 Somematerials
are used to reduce adhesions. Sepraﬁlm has the most obvious
effectiveness in these tested preparations. The effectiveness of this
material has been shown in many experimental studies.2,21
Sepraﬁlmwas applied to patients undergoing ileostomy surgery
and adhesions were evaluated when the ileostomy was closed. This
prospective, randomized, multi-center study showed that Sepra-
ﬁlm reduced the amount of adhesions in patients.22 Some rare
complications have been reported due to Sepraﬁlm, Remzi et al.
reported three non-purulent peritonitis cases secondary to Sepra-
ﬁlm which necessitated relaparotomy, but mortality was not
observed in the patients.21
HMG-CoA reductase inhibitors inhibit the rate-limiting enzyme
in the production of cholesterol. This class of drugs (statins) has a
well-studied lipid-lowering beneﬁt; however, recent studies have
revealed additional effect of statins beyond their impact on serum
cholesterol levels. They have been shown to have potent anti-
inﬂammatory, antioxidant and pro-ﬁbrinolytic properties.15,23,24
Statins are used in the treatment of and the kidney, heart, lung,
and skin ﬁbrotic diseases for their antiﬁbrotic effect owing to Rho
kinase inhibition.25e29
The idea of using statins for intra abdominal postoperative ad-
hesions was suggested because of their ﬁbrinolytic activity. Aorans
et al. found that intraperitoneal application of lovastatin and ator-
vastatin in rats reduced adhesion formation in an experimental
model. In this experimental study the tPA levels increased 57%e
379% and adhesion formation decreased 26%e58%.15 Also, Burke
et al. reported the antiﬁbrotic effects of Simvastatin which acts
inhibiting intestinal smad-3 phosphorylation.30
In our study, in the lovastatin group adhesion formation was
signiﬁcantly lower than in the control group. Lovastatin increases
tissue type plasminogen activator (tPA) and decreases plasminogen
activator inhibitor-1(PAI-1) production by humanmesothelial cells.
An increase in the tPA/PAI-1 ratio upregulates ﬁbrinolysis against
ﬁbrinogenesis and fewer adhesions are formed.31
Free oxygen radicals play an important role in intraperitoneal
adhesions which are caused by trauma, infection, or ischemia.
Oxygen radicals affect the integrity of the cell membrane and also
increase prostaglandin and thromboxane production by affecting
the metabolism of arachidonic acid and contribute to adhesion
formation. In this experimental study, NO and MDAwere evaluated
as indicators of oxidative stress. NO and MDA levels in the control
group were signiﬁcantly higher compared to the sham and study
groups and it has been shown that free oxygen radicals are effective
against adhesion formation.
Finally, we observed that lovastatin was as effective as Sepraﬁm.
MDA and NO levels in the control group were higher than the other
groups. The highest tPA value was in the lovastatin group and
there was a statistically signiﬁcant difference with the control
group (p ¼ 0.048) (p < 0.05).
In the control group one rat died during the study on the ﬁrst
postoperative day and a new rat was added. None of the rats
revealed wound infection or intra abdominal abscess.
When all these data are combined, it is seen that the anti-
adhesion effect of lovastatin deserves more detailed investigation.
Furthermore, we need to determine lovastatin’s side effects and theLovastatin Sepra P value
0.88 0.5  0.75 0.62  0.74 0.019
0.70 0.37  0.51 0.75  0.71 0.008
Fig. 1. Comparison of macroscopic adhesion values in groups. * Comparison of sham, lovastatin and sepra groups with control group separately. ** Within sham, lovastatin and sepra
groups. *** Within all groups.
Fig. 2. Comparison of microscopic adhesion values in groups. * Comparison of sham, lovastatin and sepra groups with control group separately. ** Within sham, lovastatin and sepra
groups. *** Within all groups.
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Table 2
tPA, NO and MDA values in groups.
Control group Sham group Lovastatin group Sepra group P value
tPA values (M  SD) 0.385  0.478 0.818  0.310 1.485  0.319 0.843  0.285 0.015
NO values (M  SD) 0.877  0.021 0.099  0.019 0.083  0.020 0.064  0.015 0.003
MDA values (M  SD) 1.915  0.415 1.057  0.088 0.755  0.107 0.947  0.084 0.026
M: Mean, SD: Standard Deviation.
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and this will reveal exactly, whether or not it can be used as a real
alternative to Sepraﬁlm in clinical practice.5. Conclusion
Lovastatin and Sepraﬁlm are equally effective in preventing
postoperative intra abdominal adhesions. The cost of lovastatin is
lower than that of sepraﬁlm and this is a notable advantage.References
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